Skip to main content
Top
Published in: Diabetologia 4/2007

01-04-2007 | Commentary

Mitochondrial function: use it or lose it

Authors: J. A. Hawley, S. J. Lessard

Published in: Diabetologia | Issue 4/2007

Login to get access

Excerpt

Type 2 diabetes is a progressive metabolic disorder that develops as a result of both environmental and undefined genetic factors [1]. While the precise molecular aetiology of this disorder remains elusive, there is general consensus that type 2 diabetes has several hallmark features: (1) a breakdown in lipid and carbohydrate metabolism, reflected by elevated levels of circulating metabolites and culminating in excessive deposition of fat in various tissues [2]; (2) skeletal muscle insulin resistance [3]; and (3) coordinated defects in oxidative metabolism [46]. In conjunction with these altered metabolic states is the impaired insulin signalling observed in muscle of patients with type 2 diabetes [7]. At present, it is unclear whether these (and other) defects are a consequence of the diabetic state or are instrumental in its development. Unravelling this puzzle is made more difficult because these impairments do not occur in isolation but typically co-exist in the same individual. …
Literature
1.
go back to reference Kahn CR (1994) Banting lecture. insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066–1084PubMed Kahn CR (1994) Banting lecture. insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066–1084PubMed
2.
go back to reference McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18PubMed McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18PubMed
3.
go back to reference DeFronzo RA (1992) Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389–397PubMedCrossRef DeFronzo RA (1992) Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389–397PubMedCrossRef
4.
go back to reference Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are co-ordinately downregulated in human diabetes. Nat Genet 34:267–273PubMedCrossRef Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are co-ordinately downregulated in human diabetes. Nat Genet 34:267–273PubMedCrossRef
5.
go back to reference Patti ME, Butte AJ, Crunkhorn S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466–8471PubMedCrossRef Patti ME, Butte AJ, Crunkhorn S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466–8471PubMedCrossRef
6.
go back to reference Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMedCrossRef Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMedCrossRef
7.
go back to reference Bjornholm M, Zierath JR (2005) Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochem Soc Trans 33:354–357PubMedCrossRef Bjornholm M, Zierath JR (2005) Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochem Soc Trans 33:354–357PubMedCrossRef
8.
go back to reference Hawley JA, Hargreaves M, Zierath JR (2006) Signalling mechanisms in skeletal muscle: role in substrate selection and muscle adaptation. Essays Biochem 42:1–12PubMed Hawley JA, Hargreaves M, Zierath JR (2006) Signalling mechanisms in skeletal muscle: role in substrate selection and muscle adaptation. Essays Biochem 42:1–12PubMed
9.
go back to reference Wilson DF (1994) Factors affecting the rate and energetics of mitochondrial oxidative phosphorylation. Med Sci Sports Exerc 26:37–43PubMed Wilson DF (1994) Factors affecting the rate and energetics of mitochondrial oxidative phosphorylation. Med Sci Sports Exerc 26:37–43PubMed
10.
go back to reference Kelley DE, Mintun MA, Watkins SC et al (1996) The effect of NIDDM, and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705–2713PubMedCrossRef Kelley DE, Mintun MA, Watkins SC et al (1996) The effect of NIDDM, and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705–2713PubMedCrossRef
11.
go back to reference Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171PubMed Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171PubMed
12.
go back to reference Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950PubMed Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950PubMed
13.
go back to reference Morino K, Petersen KF, Dufour S et al (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115:3587–3593PubMedCrossRef Morino K, Petersen KF, Dufour S et al (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115:3587–3593PubMedCrossRef
14.
go back to reference Petersen KF, Dufour S, Shulman GI (2005) Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2:e233PubMedCrossRef Petersen KF, Dufour S, Shulman GI (2005) Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2:e233PubMedCrossRef
15.
go back to reference Petersen KF, Befroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142PubMedCrossRef Petersen KF, Befroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142PubMedCrossRef
16.
go back to reference Schrauwen-Hinderling VB, Kooi ME, Hesselink MK et al (2007) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113–120PubMedCrossRef Schrauwen-Hinderling VB, Kooi ME, Hesselink MK et al (2007) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113–120PubMedCrossRef
17.
go back to reference Ørtenblad N, Mogensen M, Petersen I et al (2005) Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim Biophys Acta 1741:206–214PubMed Ørtenblad N, Mogensen M, Petersen I et al (2005) Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim Biophys Acta 1741:206–214PubMed
18.
19.
go back to reference Schmitz-Peiffer C (2000) Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12:583–594PubMedCrossRef Schmitz-Peiffer C (2000) Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12:583–594PubMedCrossRef
20.
go back to reference Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Della F (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia DOI 10.1007/s00125-007-0594-3 Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Della F (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia DOI 10.​1007/​s00125-007-0594-3
21.
go back to reference Hood DA, Irrcher I, Ljubicic V, Joseph AM (2006) Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209:2265–2275PubMedCrossRef Hood DA, Irrcher I, Ljubicic V, Joseph AM (2006) Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209:2265–2275PubMedCrossRef
22.
go back to reference Hawley JA (2004) Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 20:383–393PubMedCrossRef Hawley JA (2004) Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 20:383–393PubMedCrossRef
23.
go back to reference Bruce CR, Thrush AB, Mertz VA et al (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291:E99–E107PubMedCrossRef Bruce CR, Thrush AB, Mertz VA et al (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291:E99–E107PubMedCrossRef
24.
go back to reference Kump DS, Booth FW (2005) Alterations in insulin receptor signaling in the rat epitrochlearis muscle upon cessation of voluntary exercise. J Physiol 562:829–838PubMedCrossRef Kump DS, Booth FW (2005) Alterations in insulin receptor signaling in the rat epitrochlearis muscle upon cessation of voluntary exercise. J Physiol 562:829–838PubMedCrossRef
25.
go back to reference Kump DS, Booth FW (2005) Sustained rise in triacylglycerol synthesis and increased epididymal fat mass when rats cease voluntary wheel running. J Physiol 565:911–925PubMedCrossRef Kump DS, Booth FW (2005) Sustained rise in triacylglycerol synthesis and increased epididymal fat mass when rats cease voluntary wheel running. J Physiol 565:911–925PubMedCrossRef
26.
go back to reference Rimbert V, Boirie Y, Bedu M, Hocquette JF, Ritz P, Morio B (2004) Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. FASEB J 18:737–739PubMed Rimbert V, Boirie Y, Bedu M, Hocquette JF, Ritz P, Morio B (2004) Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. FASEB J 18:737–739PubMed
27.
go back to reference Bruce CR, Kriketos AD, Cooney GJ, Hawley JA (2004) Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47:23–30PubMedCrossRef Bruce CR, Kriketos AD, Cooney GJ, Hawley JA (2004) Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47:23–30PubMedCrossRef
28.
go back to reference Bruce CR, Anderson MJ, Carey AL et al (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88:5444–5451PubMedCrossRef Bruce CR, Anderson MJ, Carey AL et al (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88:5444–5451PubMedCrossRef
29.
go back to reference Zierath JR (2002) Invited review: exercise training-induced changes in insulin signaling in skeletal muscle. J Appl Physiol 93:773–781PubMed Zierath JR (2002) Invited review: exercise training-induced changes in insulin signaling in skeletal muscle. J Appl Physiol 93:773–781PubMed
30.
go back to reference Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE (2002) Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 93:3–30PubMed Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE (2002) Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 93:3–30PubMed
31.
go back to reference Beaudet AL, Scriver CR, Sly WS, Valle D (1995) Genetics, biochemistry, and molecular basis of variant human phenotypes. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease, vol 1, 7th edn. McGraw-Hill, New York, pp 79 Beaudet AL, Scriver CR, Sly WS, Valle D (1995) Genetics, biochemistry, and molecular basis of variant human phenotypes. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease, vol 1, 7th edn. McGraw-Hill, New York, pp 79
Metadata
Title
Mitochondrial function: use it or lose it
Authors
J. A. Hawley
S. J. Lessard
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0595-2

Other articles of this Issue 4/2007

Diabetologia 4/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.